Fipamezole: Completed Phase IIb enrollment

Santhera completed enrollment of 180 patients in the double-blind, dose-escalation, U.S. and Indian Phase IIb FJORD trial comparing 30, 60 and 90 mg of oral fipamezole vs. placebo for 28 days. The com...